128 related articles for article (PubMed ID: 27101583)
21. [Expression of Micro-RNA 218 in Cervical Cancer and Its Effect on Proliferation, Apoptosis and Invasion of HeLa Cells].
Shi YR; Liu J; He W; Yang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):697-702. PubMed ID: 28598082
[TBL] [Abstract][Full Text] [Related]
22. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
[TBL] [Abstract][Full Text] [Related]
23. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
24. RACK1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1.
Wu H; Song S; Yan A; Guo X; Chang L; Xu L; Hu L; Kuang M; Liu B; He D; Zhao R; Wang L; Wu X; Gu J; Ruan Y
Cancer Lett; 2020 Jan; 469():287-300. PubMed ID: 31705928
[TBL] [Abstract][Full Text] [Related]
25. Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients.
Fang H; Shuang D; Yi Z; Sheng H; Liu Y
Biomed Pharmacother; 2016 Oct; 83():64-69. PubMed ID: 27470551
[TBL] [Abstract][Full Text] [Related]
26. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
Wang N; Zhou Y; Zheng L; Li H
Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
[TBL] [Abstract][Full Text] [Related]
27. Substrate stiffness affects epithelial-mesenchymal transition of cervical cancer cells through miR-106b and its target protein DAB2.
Piao J; You K; Guo Y; Zhang Y; Li Z; Geng L
Int J Oncol; 2017 Jun; 50(6):2033-2042. PubMed ID: 28498390
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-337 inhibits cell proliferation and invasion of cervical cancer through directly targeting specificity protein 1.
Dong W; Li B; Wang J; Song Y; Zhang Z; Fu C
Tumour Biol; 2017 Jun; 39(6):1010428317711323. PubMed ID: 28641487
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance.
Yang Y; Xie YJ; Xu Q; Chen JX; Shan NC; Zhang Y
Gynecol Oncol; 2015 Sep; 138(3):683-8. PubMed ID: 26074491
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma.
Du C; Weng X; Hu W; Lv Z; Xiao H; Ding C; Gyabaah OA; Xie H; Zhou L; Wu J; Zheng S
J Exp Clin Cancer Res; 2015 Jun; 34(1):67. PubMed ID: 26126858
[TBL] [Abstract][Full Text] [Related]
31. XPNPEP2 is overexpressed in cervical cancer and promotes cervical cancer metastasis.
Cheng T; Wei R; Jiang G; Zhou Y; Lv M; Dai Y; Yuan Y; Luo D; Ma D; Li F; Xi L
Tumour Biol; 2017 Jul; 39(7):1010428317717122. PubMed ID: 28670957
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and β-catenin signalling pathways.
Liang C; Ding J; Yang Y; Deng L; Li X
Oncol Rep; 2017 Dec; 38(6):3639-3649. PubMed ID: 29130111
[TBL] [Abstract][Full Text] [Related]
33. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H
Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-150 promotes cell proliferation, migration, and invasion of cervical cancer through targeting PDCD4.
Zhang Z; Wang J; Li J; Wang X; Song W
Biomed Pharmacother; 2018 Jan; 97():511-517. PubMed ID: 29091902
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X
Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388
[TBL] [Abstract][Full Text] [Related]
36. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.
Sanches JGP; Xu Y; Yabasin IB; Li M; Lu Y; Xiu X; Wang L; Mao L; Shen J; Wang B; Hou L; Ju J; Zhao J; Song B
Chem Biol Interact; 2018 Apr; 285():85-95. PubMed ID: 29477382
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-505 predicts prognosis and acts as tumor inhibitor in cervical carcinoma with inverse association with FZD4.
Ma C; Xu B; Husaiyin S; Wang L; Wusainahong K; Ma J; Zhu K; Niyazi M
Biomed Pharmacother; 2017 Aug; 92():586-594. PubMed ID: 28577497
[TBL] [Abstract][Full Text] [Related]
39. MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer.
Pang H; Yue X
Tumour Biol; 2017 Jun; 39(6):1010428317701308. PubMed ID: 28651495
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-128 Confers Anti-Endothelial Adhesion and Anti-Migration Properties to Counteract Highly Metastatic Cervical Cancer Cells' Migration in a Parallel-Plate Flow Chamber.
Chuang PC; Lu CW; Tsai CC; Tseng SH; Su WH
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
